2009
Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD for the NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine, 2009;360:1815-26. [With Editorial Commentary]
Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O'Shea A, Callender M, Spivak A, Brennan T, Kearney MF, Proschan MA, Mican JM, Rehm CA, Coffin JM, Mellors JW, Siliciano RF, Maldarelli F. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci (USA) 2009 Jun 9;106(23):9403-8. Epub 2009 May 22
Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. American Journal of Epidemiology 2009 Jul 15;170(2):244-56.
Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, and Moore RD for the North American AIDS Cohort Collaboration on Research and Design. Trends in Multi-Drug Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced HIV-Infected Patients in North America. Clinical Infectious Diseases 2009 Nov 15;49(10):1582-90.
Chu H, Gange SJ, Li X, Hoover DR, Liu C, Chmiel JS, and Jacobson LP. The Effect of HAART on HIV RNA Trajectory among Treatment Naïve Men and Women: a Segmental Bernoulli/lognormal Random Effects Model with Left Censoring. Accepted for Publication, Epidemiology.
Abraham AG, Duncan DD, Gange SJ, West S. Computer-aided assessment of diagnostic images for epidemiological research. BMC Med Res Methodol. 2009 Nov 11;9(1):74.
Silverberg MJ, Jacobson LP, French AL, Witt MD, Gange SJ. Age and Racial/Ethnic Differences in the Prevalence of Reported Symptoms in Human Immunodeficiency Virus-Infected Persons on Antiretroviral Therapy. Journal of Pain and Symptom Management.2009 August;38(2):197-207.
Lau B, Gange SJ, Kirk GD, and Moore RD. Inferences from Clinical and Interval Cohort Studies with Application to the Evaluation of HIV Biomarkers. Epidemiology. 2009 Sep;20(5):664-72.
Terzian AS+, Holman S, Nathwani N, Robison E, Weber K, Young M, Greenblatt RM, and Gange SJ. Factors associated with preclinical disability and frailty among HIV-infected and –uninfected women in the era of cART. In Press, Journal of Women’s Health.
Cheskin LJ & Gange SJ. BMI <22.5 and >25 predicted higher overall mortality in adults. Evid Based Med. 2009 Oct;14(5):152.
Mansoor A, Althoff K, Gange S, Anastos K, DeHovitz J, Minkoff H, Kaplan R, Holman S, Lazar J. Elevated N-terminal-pro-brain natriuretic peptide levels are associated with comorbidities among HIV infected women. AIDS Research and Human Retroviruses 2009 Oct;25(10):997-1004.
Sethi AJ and Gange SJ. Parametric models as an alternative to Cox proportional hazards regression to analyze time to event data. Wisconsin Medical Journal 2009 Aug;108(5):266-8.
Liu C, Yang Y, Gange S, Weber K, Sharp G, Wilson T, Levine A, Robison E, Gandhi M, Merenstein D. Disclosure of complimentary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDS. 2009 Oct 12. [Epub ahead of print]
Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, and Greenblatt RM. NNRTI pharmacokinetics in a large unselected cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91.
Ganesan A, Benning L, Golub ET, Riddle M, Crum-Cianflone N, Tasker S, Jacobson L, and Gange SJ. Serum Lipid Profiles among Patients Initiating Ritonavir-Boosted Atazanavir versus Efavirenz-Based Regimens. AIDS Res Ther. 2009 Jun 22;6:13.
Templeton AR, Kramer MG, Jarvis J, Kowalski J, Gange S, Schneider MF, Shao Q, Zhang GW, Yeh MF, Tsai HL, Zhang H, and Markham RB. Multiple-infection and Recombination in HIV-1 Within A Longitudinal Cohort of Women. Retrovirology 2009 Jun 3;6(1):54.
Galarraga O+, Salkever DS, Cook JA, Gange SJ. An instrumental variable evaluation of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004. Accepted for publication, Health Economics. Also published in early form as a 2006 National Bureau of Economic Research Working Paper (#12619).
Phelan DF+, Gange SJ, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P. Determinants of Newly Detected Human Papillomavirus Infection in HIV-Infected and HIV-Uninfected Injection Drug Using Women. Sex Transm Dis. 2009;36(3):149-156.
Feldman DN, Feldman JG, Greenblatt RM, Anastos K, Pearce L, Cohen MH, Gange SJ, Leanza S, and Burk R. CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. AIDS Educ Prev 2009;21(3):
Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, and Greenblatt RM. Protease Inhibitor Levels in Hair Samples Strongly Predict Virologic Responses to HIV Treatment. AIDS 2009 Feb 20;23(4):471-478.
Kowalski J, Gange SJ, Schneider MF, Tsai H-L, Templeton A, Shao Q, Zhang QW, Yeh MF, Young M, and Markham RB. Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene. J Acquir Immune Defic Syndr 2009;50:381–389.
2008
Golub ET, Benning L, Sharma A, Gandhi M, Cohen M, Young M, and Gange SJ. Patterns, Predictors, and Consequences of Initial Regimen Type among HIV-infected Women Initiating HAART. Clinical Infectious Diseases 2008;46:305-12.
Strickler HD, Fazzari M, Kovacs A, Isasi C, Napolitano LA, Minkoff H, Gange S, Young M, Sharp GB, Kaplan RC, Cohen M, Gunter MJ, Harris TG, Yu H, Schoenbaum E, Landay AL, Anastos K. Associations of Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3) with HIV Disease Progression in Women. Journal of Infectious Diseases 2008 Jan 15;197(2):319-27.
Strickler HD, Howard AA, Peters M, Fazzari M, Yu H, Augenbraun M, Burk RD, French AL, Kaplan RC, Young M, Gange S, Xue X, Harris TG, Anastos K, Kovacs A. The insulin-like growth factor axis and risk of liver disease in HCV/HIV co-infected women. AIDS 2008 Feb 19;22(4):527-31.
Gange SJ. Teaching Epidemiologic Methods. Epidemiology 2008;19:353-6.
Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, and Greenblatt RM. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a representative group of HIV-infected women in the United States. JAIDS 2008 Mar 1;47(3):377-83.
Harris TG, Burk RD, Yu H, Minkoff H, Massad LS, Watts DH, Zhong Y, Gange S, Kaplan RC, Anastos K, Levine AM, Moxley M, Xue X, Fazzari M, Palefsky JM, Strickler HD. The Insulin-like Growth Factor (IGF)-axis and Oncogenic Human Papillomavirus Natural History. Cancer Epidemiology, Biomarkers, & Prevention 2008 Jan;17(1):245-8.
Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, and Gray R. Determinants of Incidence and Clearance of High-Risk Human Papillomavirus Infections in Rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev 2008;17 1300-1307
Safaeian M, Kiduggavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Muroka D, Sklar M, Serwada D, Wawer MJ, Shah KV, Gray R. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sex Transm Infect. 2008 Aug;84(4):306-11.
Lau B, Cole SR, Moore RD, Gange SJ. Evaluating competing adverse and beneficial outcomes using a mixture model. Stat Med. 2008 Sep 20;27(21):4313-27.
Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, Anastos K, Tien PC, Sharrett AR, Hodis HN. Subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected women and men. AIDS, 2008;22(13):1615-24. [With Editorial Commentary]
Egner P, Kensler T, Chen J, Gange S, Groopman J, Friesen M. Quantification of Sulforaphane Mercapturic Acid Pathway Conjugates in Human Urine by High-Performance Liquid Chromatography and Isotope-Dilution Tandem Mass Spectrometry. Chem Res Toxicol. 2008 Oct;21(10):1991-6.
+ Students or supervised staff
